InfuSystem Holdings, Inc. has announced a significant change in its auditing firm as part of its ongoing governance and operational strategy. The company's Audit Committee conducted a competitive selection process to appoint a new independent registered public accounting firm for the fiscal year ending December 31, 2026. Following this process, the Committee approved the dismissal of Deloitte & Touche LLP, which had served as the company's auditor for the previous fiscal year. The new firm, Grant Thornton LLP, will now be responsible for auditing InfuSystem's consolidated financial statements and reviewing quarterly financial statements for the upcoming fiscal year. This transition comes after a thorough evaluation of proposals from several firms, indicating a proactive approach by the company to ensure robust financial oversight. Notably, during the fiscal years ended December 31, 2025 and 2024, there were no disagreements between InfuSystem and Deloitte regarding accounting principles or practices, which suggests a smooth transition. The company has also confirmed that Deloitte's audit reports for the previous years contained no adverse opinions, indicating a clean audit history. The change in auditors is part of InfuSystem's commitment to maintaining high standards of governance and operational execution, although it may raise concerns among investors regarding continuity and the potential impact on financial reporting. The company has provided Deloitte with a copy of the disclosures in this Current Report on Form 8-K and has requested a letter from Deloitte to the SEC regarding their agreement with the statements made. This move is expected to have a small negative effect on the stock price as investors may view the change as a sign of instability in the company's financial governance.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.